Vetacalm
Vetacalm Brand names, Vetacalm Analogs
Vetacalm Brand Names Mixture
- No information avaliable
Vetacalm Chemical_Formula
C18H18ClNS
Vetacalm RX_link
No information avaliable
Vetacalm fda sheet
Vetacalm msds (material safety sheet)
Vetacalm Synthesis Reference
No information avaliable
Vetacalm Molecular Weight
315.861 g/mol
Vetacalm Melting Point
97.5 oC
Vetacalm H2O Solubility
0.295 mg/L
Vetacalm State
Solid
Vetacalm LogP
5.654
Vetacalm Dosage Forms
Tablets; Syrup (concentrate)
Vetacalm Indication
For treatment of psychotic disorders (e.g. schizophrenia) and of acute mania occuring as part of bipolar disorders.
Vetacalm Pharmacology
Chlorprothixene is a typical antipsychotic drug of the thioxanthine class. It has a low antipsychotic potency (half to 2/3 of chlorpromazine). An intrinsic antidepressant effect of chlorprothixene has been discussed, but not proven yet. Likewise, it is unclear, if chlorprothixene has genuine analgesic effects. An antiemetic effect, as with most antipsychotics, exists. It is used in the treatment of nervous, mental, and emotional conditions. Improvement in such conditions is thought to result from the effect of the medicine on nerve pathways in specific areas of the brain. Chlorprothixene has a strong sedative activity with a high incidence of anticholinergic side-effects. Chlorprothixene is structurally related to chlorpromazine, with which it shares in principal all side effects. Allergic side-effects and liver damage seem to appear with an appreciable lower frequency.
Vetacalm Absorption
No information avaliable
Vetacalm side effects and Toxicity
Symptoms of overdose include difficulty in breathing (severe), dizziness (severe), drowsiness (severe), muscle trembling, jerking, stiffness, or uncontrolled movements (severe), small pupils, unusual excitement, and unusual tiredness or weakness (severe).
Vetacalm Patient Information
Vetacalm Organisms Affected
Humans and other mammals
